Also from this source

You just read:

Jupiter Orphan Therapeutics Announces Submission of Investigational New Drug Application (IND) For Treatment Of Mucopolysaccharidosis Type-I

News provided by

Jupiter Orphan Therapeutics, Inc.

Mar 14, 2018, 07:35 ET